Valiant Organics Ltd
Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]
- Market Cap ₹ 923 Cr.
- Current Price ₹ 335
- High / Low ₹ 519 / 307
- Stock P/E
- Book Value ₹ 260
- Dividend Yield 0.00 %
- ROCE 1.07 %
- ROE -0.91 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.88% over past five years.
- Company has a low return on equity of 10.0% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE SmallCap BSE Commodities BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|
692 | 675 | 755 | 1,153 | 1,052 | 723 | 646 | |
511 | 494 | 550 | 948 | 888 | 686 | 630 | |
Operating Profit | 181 | 181 | 205 | 205 | 164 | 37 | 17 |
OPM % | 26% | 27% | 27% | 18% | 16% | 5% | 3% |
8 | 6 | 6 | 7 | 13 | 6 | -4 | |
Interest | 4 | 3 | 5 | 6 | 11 | 16 | 24 |
Depreciation | 14 | 16 | 21 | 30 | 29 | 35 | 35 |
Profit before tax | 171 | 168 | 185 | 176 | 137 | -9 | -46 |
Tax % | 29% | 25% | 29% | 27% | 25% | -3% | |
121 | 126 | 131 | 128 | 103 | -8 | -41 | |
EPS in Rs | 103.65 | 51.00 | 42.19 | 41.72 | 32.45 | -3.04 | -15.03 |
Dividend Payout % | 6% | 11% | 12% | 8% | 3% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 1% |
3 Years: | -1% |
TTM: | -30% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -152% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -13% |
3 Years: | -32% |
1 Year: | -29% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 16% |
3 Years: | 10% |
Last Year: | -1% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 6 | 12 | 27 | 27 | 27 | 28 | 28 |
Reserves | 254 | 374 | 475 | 586 | 662 | 702 | 689 |
77 | 140 | 210 | 364 | 274 | 257 | 202 | |
112 | 143 | 165 | 216 | 276 | 262 | 255 | |
Total Liabilities | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,173 |
150 | 276 | 510 | 543 | 670 | 643 | 637 | |
CWIP | 66 | 129 | 46 | 112 | 71 | 86 | 90 |
Investments | 12 | 23 | 6 | 8 | 41 | 99 | 94 |
221 | 241 | 314 | 529 | 457 | 420 | 352 | |
Total Assets | 448 | 669 | 876 | 1,192 | 1,239 | 1,248 | 1,173 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
76 | 161 | 115 | -31 | 238 | 84 | |
-86 | -184 | -159 | -124 | -143 | -65 | |
1 | 27 | 49 | 167 | -112 | -23 | |
Net Cash Flow | -9 | 5 | 5 | 12 | -17 | -4 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|
Debtor Days | 75 | 72 | 76 | 102 | 88 | 106 |
Inventory Days | 44 | 42 | 66 | 54 | 68 | 88 |
Days Payable | 69 | 82 | 97 | 63 | 89 | 159 |
Cash Conversion Cycle | 50 | 32 | 44 | 93 | 67 | 34 |
Working Capital Days | 63 | 42 | 63 | 103 | 81 | 88 |
ROCE % | 39% | 30% | 21% | 14% | 1% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Investor Presentation
3 Dec - Q2 FY-25 results presentation by Valiant Organics.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Dec
-
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
2 Dec - Notice of Postal Ballot and E-voting for approvals.
-
Intimation Of Communication Received From Stock Exchanges.
22 Nov - Company disputes fines for non-compliance with SEBI regulations.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 15 Nov
Annual reports
Concalls
-
Dec 2024TranscriptNotesPPT
-
Aug 2024TranscriptNotesPPT
-
Jun 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Sep 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Mar 2022TranscriptNotesPPT
-
Mar 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Sep 2021TranscriptNotesPPT
Business Overview:[1][2][3]
VOL is is promoted by Gogri, Chedda and Gala families. It is a manufacturer and seller of specialty chemicals. It is one of the largest manufacturers of chlorophenol derivatives, Benzene derivatives, PNA, PAP, Ortho Anisidine and Para Anisidine. Company has a client base across Pharmaceuticals, Dyes & Pigments, Agrochemicals, specialty chemicals, and veterinary medications